Circulating endothelin-1 levels in systemic sclerosis subsets--a marker of fibrosis or vascular dysfunction?
Morelli, S.; Ferri, C.
Journal of Rheumatology 23(4): 789-791
1996
ISSN/ISBN: 0315-162X PMID: 8730152 Document Number: 460333
Document emailed within 1 workday
Related Documents
Yamane, K.; Ihn, H.; Kubo, M.; Yazawa, N.; Kikuchi, K.; Soma, Y.; Tamaki, K. 2000: Serum levels of KL-6 as a useful marker for evaluating pulmonary fibrosis in patients with systemic sclerosis Journal of Rheumatology 27(4): 930-934Kiener, H.; Graninger, W.; Machold, K.; Aringer, M.; Graninger, W.B. 1994: Increased levels of circulating intercellular adhesion molecule-1 in patients with systemic sclerosis Clinical and Experimental Rheumatology 12(5): 483-487
Caligaris-Cappio, F.; Bertero, M.T.; Converso, M.; Stacchini, A.; Vinante, F.; Romagnani, S.; Pizzolo, G. 1995: Circulating levels of soluble CD30, a marker of cells producing Th2-type cytokines, are increased in patients with systemic lupus erythematosus and correlate with disease activity Clinical and Experimental Rheumatology 13(3): 339-343
Stewart, D.J. 1990: Endothelin-1--marker or mediator of vascular disease? Canadian Journal of Cardiology 6(8): Viii
Ogawa, T.; Saito, E. 1999: Systemic sclerosis: different subsets and disease remitting drugs Nihon Rinsho. Japanese Journal of Clinical Medicine 57(2): 344-348
LeRoy, E.C.; Black, C.; Fleischmajer, R.; Jablonska, S.; Krieg, T.; Medsger, T.A.; Rowell, N.; Wollheim, F. 1988: Scleroderma (systemic sclerosis): classification, subsets and pathogenesis Journal of Rheumatology 15(2): 202-205
Kopiński, P.; Nalepa, P.; Wojas-Pelc, A.; Janowska, E.; Gil, K. 2000: Changes in lymphocyte subsets in bronchoalveolar lavage fluid in patients with systemic sclerosis Polski Merkuriusz Lekarski: Organ Polskiego Towarzystwa Lekarskiego 7(43): 18-22
Corrado, A.; Neve, A.; Costantino, E.; Palladino, G.P.; Foschino Barbaro, M.P.; Cantatore, F.P. 2013: Effect of endothelin inhibition on lung fibroblasts on patients with systemic sclerosis Minerva Medica 104(5): 505-517
Ertenli, I.; Kiraz, S.; Ertürk, H.; Haznedaroglu, I.C.; Celik, I.; Calgüneri, M.; Kirazli, S. 1999: Circulating thrombopoietin in systemic sclerosis Journal of Rheumatology 26(9): 1939-1941
Shalev, L.; Langevitz, P.; Zandman-Goddard, G. 2008: Long-term therapy with endothelin-1 antagonist for pulmonary hypertension secondary to systemic sclerosis Harefuah 147(4): 287-289; 376
Malaviya, A.N.; Rajagopalan, P.; Gupta, S.; Taneja, R.L. 1980: Cryoglobulinemia and circulating immune complexes in progressive systemic sclerosis Indian Journal of Medical Research 72: 359-364
Tombul, T.; Anlar, O.; Tuncer, M.; Huseyinoglu, N.; Eryonucu, B. 2011: Impaired heart rate variability as a marker of cardiovascular autonomic dysfunction in multiple sclerosis Acta Neurologica Belgica 111(2): 116-120
Becker, G.J.; Perkovic, V.; Hewitson, T.D. 2001: Pharmacological intervention in renal fibrosis and vascular sclerosis Journal of Nephrology 14(5): 332-339
Kaye, S.A.; Siraj, Q.H.; Agnew, J.; Hilson, A.; Black, C.M. 1996: Detection of early asymptomatic esophageal dysfunction in systemic sclerosis using a new scintigraphic grading method Journal of Rheumatology 23(2): 297-301
Dantas, R.O.; Villanova, M.G.; de Godoy, R.A. 1985: Esophageal dysfunction in patients with progressive systemic sclerosis and mixed connective tissue diseases Arquivos de Gastroenterologia 22(3): 122-126
Juan, C.C.; Fang, V.S.; Hsu, Y.P.; Huang, Y.J.; Hsia, D.B.; Yu, P.C.; Kwok, C.F.; Ho, L.T. 1998: Overexpression of vascular endothelin-1 and endothelin-A receptors in a fructose-induced hypertensive rat model Journal of Hypertension 16(12 Pt 1): 1775-1782
Nishioka, Y.; Miyazaki, M.; Nishino, T.; Bando, Y.; Harada, T.; Taguchi, T.; Kohno, S. 2004: A case of chronic renal insufficiency due to vascular injury of systemic sclerosis Nihon Jinzo Gakkai Shi 46(7): 709-714
Vacca, A.; Cormier, C.; Mathieu, A.; Kahan, A.é; Allanore, Y. 2011: Vitamin D levels and potential impact in systemic sclerosis Clinical and Experimental Rheumatology 29(6): 1024-1031
Wu, H.; Chen, H.; Hu, P.C. 2007: Circulating Endothelial Cells and Endothelial Progenitors as Surrogate Biomarkers in Vascular Dysfunction Clinical Laboratory 53(5-6): 285-295
Riccieri, V.; Parisi, G.; Spadaro, A.; Scrivo, R.; Barone, F.; Moretti, T.; Bernardini, G.; Strom, R.; Taccari, E.; Valesini, G. 2005: Reduced circulating natural killer T cells and gamma/delta T cells in patients with systemic sclerosis Journal of Rheumatology 32(2): 283-286